IEX Earnings Prediction
The chart below shows how IEX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IEX sees a +1.16% change in stock price 10 days leading up to the earnings, and a +2.12% change 10 days following the report. On the earnings day itself, the stock moves by +0.25%. This data can give you a slight idea of what to expect for the next quarter's release.
IEX Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
862.90M
9.38%
8.11%
Gross Margin
42.54%
-0.35%
-4.06%
Operating Margin
19.61%
-9.25%
-11.31%
Net Margin
14.28%
4.01%
-4.16%
EPS
1.62
13.29%
3.18%
No Data Available
IEX Earnings Analysis
IDEX Corp Corporation (IEX.N) Earnings Conference Call
Positive
Strong Demand in Q4 Orders: Fourth quarter orders of $817 million were up approximately 8% on a reported basis and up 5% organically, indicating strong demand across the portfolio, particularly in the Health and Science Technology segment.
Fourth Quarter Sales Surge: Fourth quarter sales reached $863 million, reflecting a 9% increase on a reported basis and a 3% organic growth, driven by robust performance in the Fire Safety and Diversified Product segment.
Improved EBITDA Margin: Adjusted EBITDA margin for the fourth quarter improved by 60 basis points to 26.4%, showcasing enhanced operational productivity and effective cost management strategies.
Strong Cash Generation: Free cash flow for the quarter was $157 million, achieving a conversion rate of 101% of adjusted net income, demonstrating strong cash generation capabilities.
Cash Dividends Paid: The company paid $205 million in cash dividends to shareholders in 2024, reflecting a commitment to returning value to shareholders while maintaining a strong balance sheet.
Negative
Sales Growth Analysis: Fourth quarter sales of $863 million were up 9% reported but only up 3% organically compared to the prior year, indicating a slowdown in organic growth.
Sales Performance Overview: Full year sales of $3.3 billion were flat overall and down 2% organically, with HST contracting by 7% on an organic basis due to life sciences and semiconductor cyclical market headwinds.
Gross Margin Decline Analysis: Fourth quarter gross margin declined 20 basis points to 42.5% on a reported basis, reflecting higher employee-related costs and unfavorable mix despite operational productivity gains.
EBITDA Margin Decline: Full-year adjusted EBITDA margin contracted 80 basis points to 26.7%, indicating a decline in profitability despite some operational improvements.
Organic Revenue Decline Forecast: Organic revenue is expected to decline 3% to 4% in the first quarter of 2025 compared to the prior year, reflecting challenges in key end markets.
IEX FAQs
How does IEX typically perform around its earnings report dates?
Is IDEX Corp (IEX) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
IEX Earning Call Sentiment
IDEX Corporation (NYSE:IEX) Q4 2024 Earnings Call Transcript
IEX.N
-0.79%Positive
The earnings call reveals mixed signals. Financial performance shows stable sales and margins, but geopolitical tensions and integration risks pose uncertainties. The Q&A indicates cautious optimism, with some segments expected to decline. The absence of a share repurchase program and increased debt levels add concerns. Despite some positive aspects like a stable customer tone and operational improvements, the overall sentiment remains neutral due to potential risks and uncertainties.
